Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Outcomes of ritonavir-boosted protease inhibitor versus non-nucleoside reverse transcriptase regimens in a clinical practice cohort
Richard D. Moore
, Ritesh Kumar
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Outcomes of ritonavir-boosted protease inhibitor versus non-nucleoside reverse transcriptase regimens in a clinical practice cohort'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Proteinase Inhibitor
100%
RNA Directed DNA Polymerase
100%
Ritonavir
100%
Nucleoside
100%
Nonnucleoside Reverse Transcriptase Inhibitor
60%
Quality of Life
40%
Adverse Event
40%
Log Rank Test
20%
Highly Active Antiretroviral Therapy
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase Inhibitor
100%
RNA Directed DNA Polymerase
100%
Nucleoside
100%
Ritonavir
100%
Nonnucleoside Reverse Transcriptase Inhibitor
60%
Adverse Event
40%
Keyphrases
Non-nucleoside Reverse Transcriptase
100%
Development Failure
20%
Nursing and Health Professions
RNA Directed DNA Polymerase
100%